文献速递中医内科中医儿科

儿童过敏性紫癜肾炎血热证生物学基础的多维分析

The biological basis of Blood-Heat syndrome in children with Henoch-Schonlein purpura nephritis: a multidimensional analysis based on clinical proteomics and an animal model.
PubMed 文献 · Front Pharmacol · 2026-04-10

本研究采用临床蛋白质组学与动物模型,探讨儿童过敏性紫癜肾炎(HSPN)血热证的生物学基础。发现87个差异蛋白,富集于鞘脂信号通路(P=0.02),鉴定9个核心生物标志物,ELISA验证AHSG、HRG、KNG1下调,其余6个上调(P<0.01),大鼠模型可重复。提出「血热相关应激-鞘脂信号关联改变-ERK2介导炎症放大」假说。

要点

  • HSPN血热证存在可重复的分子表型,涉及鞘脂信号通路与炎症背景增强。
  • 9个核心生物标志物(AHSG、HRG、KNG1、HP、AZGP1、PTX3、MAPK1、A1BG、COL1A1)AUC均≥0.7,有诊断潜力。
  • ELISA验证AHSG、HRG、KNG1在血热组显著下调,其余6个显著上调(P<0.01),大鼠模型可重复。

核心结论

  • HSPN血热证具有可重复的分子表型,差异蛋白功能富集涉及鞘脂信号通路,并伴以ERK2上调为代表的炎症背景增强。
  • 提出「血热相关应激-鞘脂信号关联改变-ERK2介导炎症放大」核心科学假说,为机制验证和靶向干预提供方向。

研究设计与样本

  • 临床研究分发现队列与验证队列:发现队列用DIA蛋白质组学分析HSPN血热证(n=15)、非血热证(n=30)和健康对照(n=30)血清。
  • 验证队列独立纳入血热证(n=30)和非血热证(n=30),用ELISA验证发现队列及验证队列。
  • 基础研究建立HSPN合并血热证大鼠模型以复现临床发现。

主要发现

  • 蛋白质组学鉴定87个与血热证相关的特异性差异表达蛋白(DEPs)。
  • KEGG分析显示鞘脂信号通路显著富集(P=0.02)。
  • 鉴定9个核心生物标志物(AHSG、HRG、KNG1、HP、AZGP1、PTX3、MAPK1、A1BG、COL1A1),区分健康对照与血热证、血热证与非血热证的AUC值均≥0.7。
  • ELISA验证显示,与健康对照和非血热组相比,血热组AHSG、HRG、KNG1显著下调,其余6个标志物显著上调(P<0.01)。
  • 上述趋势在HSPN血热证大鼠模型中完全复现。

关键数值与推荐

  • 血热证相关差异蛋白87个,鞘脂信号通路富集P=0.02。
  • 9个核心标志物诊断AUC均≥0.7。
  • ELISA验证组间比较P<0.01(血热组vs健康对照和非血热组)。

临床怎么用

  • 血热证辨证可参考9个核心生物标志物的表达趋势,辅助客观化识别HSPN血热证。
  • 鞘脂信号通路和ERK2上调提示血热证可能存在炎症放大背景,可作为未来靶向干预的候选方向。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Blood-Heat syndrome is a core syndrome of Traditional Chinese Medicine (TCM) in Henoch-Schönlein purpura nephritis (HSPN), yet its biological basis remains unclear. This study aimed to systematically elucidate the scientific basis of Blood-Heat syndrome within the context of HSPN and to identify its objective biomarkers using a multidimensional biological approach. METHODS: In the clinical research part, we divided it into a discovery cohort and a validation cohort. The discovery cohort employed Data-Independent Acquisition (DIA) proteomics technology to analyze serum samples from HSPN patients with Blood-Heat syndrome (n = 15), those without Blood-Heat syndrome (non-Blood-Heat, n = 30), and healthy controls (n = 30). The findings were then validated through ELISA in both the discovery cohort and an independent validation cohort (n = 30 for blood heat syndrome, n = 30 for non-blood heat syndrome). In the basic research component, we established a rat model combining HSPN with Blood-Heat syndrome to replicate the clinical findings. RESULTS: Proteomic analysis identified 87 specific differentially expressed proteins (DEPs) associated with Blood-Heat syndrome. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed significant enrichment in the sphingolipid signaling pathway (P = 0.02). We further identified a panel of nine core biomarkers (AHSG, HRG, KNG1, HP, AZGP1, PTX3, MAPK1, A1BG, and COL1A1), which demonstrated excellent diagnostic performance in distinguishing between healthy control group and blood-heat syndrome, as well as between blood-heat syndrome and non-blood-heat syndrome (with AUC values all ≥0.7). ELISA validation showed that, compared to the healthy control group and non-Blood-Heat group, the levels of AHSG, HRG, and KNG1 were significantly downregulated in the Blood-Heat group, while the other six markers were significantly upregulated (P < 0.01 for all). This trend was fully replicated in the HSPN Blood-Heat syndrome rat model. CONCLUSION: Based on multidimensional evidence from clinical proteomics and animal model replication, this study suggests that Blood-Heat syndrome in the context of HSPN has a reproducible molecular phenotype. The functional enrichment of its differential proteins involves the sphingolipid signaling pathway, accompanied by an enhanced inflammatory background represented by ERK2 upregulation. Based on these findings, we propose a core scientific hypothesis of "Blood-Heat-related stress-sphingolipid signaling-associated alterations-ERK2-mediated inflammatory amplification," providing a direction for future mechanistic validation and targeted intervention research.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Xu S, Xu Y, Bi Y, et al. The biological basis of Blood-Heat syndrome in children with Henoch-Schonlein purpura nephritis: a multidimensional analysis based on clinical proteomics and an animal model. Front Pharmacol. 2026. PMID: 42038305. doi:10.3389/fphar.2026.1778919

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。